SCHEMBL25752841

SCHEMBL25752841

COC(=O)C[C@H](N)c1cc(C)ccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TNF P01375 2/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
CTSA P10619 1/20 0.38
TAS1R3 Q7RTX0 2/20 0.37
TAS1R1 Q7RTX1 2/20 0.37
TAS1R2 Q8TE23 2/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31750509 0.82 MAPT (0.49) MAPTKDM4EL3MBTL1CYP1A2CYP3A4
SCHEMBL25753702 0.82 MAPT (0.49) MAPTKDM4EL3MBTL1CYP1A2CYP3A4
SCHEMBL25752840 0.82 MAPT (0.40) MAPTHSD17B10HTTCTSAKDM4E
SCHEMBL5769080 0.81 CASP1 (0.44) MAPTLMNAHTTCTSAMEN1
SCHEMBL5693549 0.81 CASP1 (0.44) MAPTLMNAHTTCTSAMEN1
SCHEMBL14417347 0.81 CASP1 (0.44) MAPTLMNAHTTCTSAMEN1
SCHEMBL5862004 0.77 LMNA (0.47) MAPTTNFLMNAHTTL3MBTL1
SCHEMBL13802834 0.76 CYP1A2 (0.49) MAPTHSD17B10LMNATAS1R3TAS1R1
SCHEMBL5045992 0.76 ALDH1A1 (0.44) MAPTTNFLMNAHTTL3MBTL1
SCHEMBL17167378 0.76 ALDH1A1 (0.44) MAPTTNFLMNAHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 MAPT 3157/4885HSD17B10 481/4885TNF 4836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.